Tradestie Institutional Equity Comparison Engine

DSPY vs CANC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DSPY Overall Edge

DSPY Captures Institutional Edge (1โ€“0 Pillars ยท 3โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to DSPY (DSPY) driven by superior Momentum & Technical. Fundamentally, DSPY trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CANC at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, DSPY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CANC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
DSPY N/M vs CANC N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner DSPY
1Y +13.2% vs +22.7% ยท 52W Pos 73% vs 52%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
DSPY US Equity
DSPY
Institutional Equity
$64.97
-1.71% 1D
Market Cap N/A
1M Return -1.62%
1Y Return +13.23%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 47.0 Fund 52.0 Flow 50.0 Mom 50.0
CANC NASDAQ
Tema Oncology ETF
Institutional Equity
$40.26
-1.95% 1D
Market Cap N/A
1M Return +1.55%
1Y Return +22.71%
Forward P/E N/M
Unified AI Score
48.5 / 100 HOLD
Tech 43.0 Fund 48.0 Flow 50.0 Mom 56.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DSPY +13.23% CANC +22.71% Spread: +9.48 pp (CANC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DSPY TTM Op. Margin: N/A CANC TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DSPY vs CANC. Trailing 12-month operating profitability (DSPY N/A vs CANC N/A) and valuation multiples (DSPY N/M vs CANC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DSPY (3) vs CANC (0)
Institutional Metric DSPY CANC Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 73% ($56โ€“$68) 52% ($33โ€“$47) Stronger Trend DSPY
Beta / 30D Volatility Risk Regime 0.90ฮฒ ยท 21% Vol 0.89ฮฒ ยท 33% Vol Lower Realized Risk DSPY
Unified Institutional Score Composite Signal 52.1 / 100 (HOLD) 48.5 / 100 (HOLD) Higher Composite DSPY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DSPY vs CANC Buy Guide
DSPY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DSPY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CANC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CANC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DSPY nor CANC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.